Measurement of PD-1, TIM-3 and LAG-3 protein in non-small cell lung carcinomas (NSCLCs) with acquired resistance to PD-1 axis blockers.

被引：4
|
作者：
Datar, Ila
Mani, Nikita
Henick, Brian S.
Wurtz, Anna
Kaftan, Edward
Herbst, Roy S.
Rimm, David L.
Gettinger, Scott N.
Politi, Katerina A.
Schalper, Kurt Alex
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e14611
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14611
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Simultaneous measurement and clinical significance of PD-1, LAG-3 and TIM-3 in non-small cell lung cancer (NSCLC)
    Datar, Ila J.
    Wang, Jun
    Mani, Nikita
    Villarroel-Espindola, Franz
    Ryan, Patrick
    Sanmamed, Miguel F.
    McEachern, Kristen
    Jenkins, David
    Rimm, David L.
    Chen, Leiping
    Herbst, Roy
    Schalper, Kurt
    CANCER RESEARCH, 2017, 77
  • [2] Expression and function of PD-1 and TIM-3 in non-small cell lung cancer (NSCLC)
    Travers, Jonathan
    McEachern, Krtisten
    Ghosh, Srimoyee
    Ramaswamy, Sridhar
    Jenkins, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] In patients with advanced non-small cell lung cancer (NSCLC) LAG-3 is expressed on activated TILs and predicts resistance to PD-1 axis blockers
    Datar, I.
    Sanmamed, M. F.
    Choi, J.
    Wang, J.
    Henick, B. S.
    Badri, T.
    Mejias, L. D.
    Lozano, M.
    Gracia, J. L.
    Velcheti, V.
    Herbst, R.
    Melero, I.
    Chen, L.
    Schalper, K. A.
    ANNALS OF ONCOLOGY, 2017, 28 : 5 - 5
  • [4] Targeting PD-1, TIM-3 and LAG-3 in combination for improved immunotherapy combinations
    Kehry, Marilyn
    Horlick, Robert
    Bowers, Peter
    Jun, Toni
    Correia, Jean da Silva
    Graves, Jonathan
    Wang, Yan
    Laken, Haley
    King, David J.
    CANCER RESEARCH, 2015, 75
  • [5] Simultaneous measurement and significance of PD-1, LAG-3 and TIM-3 expression in human solid tumors
    Morgado, Micaela
    Datar, Ila
    Wang, Jun
    Sanmamed, Miguel F.
    McEachern, Kristen
    Jenkins, David
    Chen, Lieping
    Carvajal-Hausdorf, Daniel
    Rimm, David L.
    Herbst, Roy S.
    Schalper, Kurt A.
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
    Bruss, Christina
    Kellner, Kerstin
    Albert, Veruschka
    Hutchinson, James A.
    Seitz, Stephan
    Ortmann, Olaf
    Brockhoff, Gero
    Wege, Anja K.
    CANCERS, 2023, 15 (09)
  • [7] Serum Concentrations of TIM-3, LAG-3, and PD-1 in Patients with Hemorrhagic Fever with Renal Syndrome
    Safranko, Zeljka Macak
    Jakopec, Lana
    Svagusa, Karla
    Krajinovic, Lidija Cvetko
    Tomasovic, Domagoj
    Lukic, Ljiljana
    Markotic, Alemka
    LIFE-BASEL, 2024, 14 (05):
  • [8] Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis
    Datar, Ila
    Sanmamed, Miguel F.
    Wang, Jun
    Henick, Brian S.
    Choi, Jungmin
    Badri, Ti
    Dong, Weilai
    Mani, Nikita
    Toki, Maria
    Mejias, Luis D.
    Lozano, Maria D.
    Luis Perez-Gracia, Jose
    Velcheti, Vamsidhar
    Hellmann, MatthewD.
    Gainor, Justin F.
    McEachern, Kristen
    Jenkins, David
    Syrigos, Konstantinos
    Politi, Katerina
    Gettinger, Scott
    Rimm, David L.
    Herbst, Roy S.
    Melero, Ignacio
    Chen, Lieping
    Schalper, Kurt A.
    CLINICAL CANCER RESEARCH, 2019, 25 (15) : 4663 - 4673
  • [9] Perspectives on Acquired Resistance to PD-1 Axis Inhibitors in Patients with Non-Small Cell Lung Cancer
    Tseng, Diane
    Padda, Sukhmani K.
    Wakelee, Heather A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (06) : 741 - 744
  • [10] Assessment of the expression and response of PD-1, LAG-3, and TIM-3 after neoadjuvant radiotherapy in rectal cancer
    Peng, Qing-Qin
    Li, Jin-Luan
    Xin, Pei-Ling
    Du, Kai-Xin
    Lin, Xiao-Yi
    Wu, Jun-Xin
    Zhang, Mu-Tian
    Kong, Xiang-Quan
    NEOPLASMA, 2021, 68 (04) : 742 - +
12345